Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/4400205.

Title:
Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis | Cell Death & Differentiation
Description:
Members of the the Bcl-2 and ICE/ced-3 gene families have been implicated as essential components in the control of the cell death pathway. Bcl-2 overexpression can prevent programmed cell death (PCD) in different cell types. ICE/ced-3-like proteases are synthesized as pro-enzymes and are activated by limited proteolysis. When overexpressed in diverse cell types, they trigger PCD. Bcl-2 can inhibit PCD mediated by these proteases, although as yet it is not clear at what specific step in the cell death pathway the protein acts. Here, we demonstrate that CPP32/Yama/Apopain, a member of the ICE/Ced-3 gene family, is processed during staurosporine-induced apoptosis in HeLa cells and that concomitant with CPP32 activation, two other proteins, poly (ADP-ribose) polymerase (PARP) and the U1-70 K small ribonucleoprotein, also undergo proteolysis. Overexpression of Bcl-2 prevents cleavage of CPP32, PARP and U1-70 K and protects HeLa cells from PCD. These results demonstrate that Bcl-2 controls PCD, by acting upstream of CPP32/Yama/Apopain.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Telecommunications
  • Social Networks
  • Mobile Technology & AI

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,556,742 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$536,300 per month
Our analysis indicates Nature.com generates between $357,519 and $983,176 monthly online from display ads.

Keywords {🔍}

nature, bcl, cell, article, death, content, cookies, privacy, cpp, apoptosis, pcd, data, information, activation, poly, polymerase, proteins, rodriguez, open, advertising, differentiation, prevents, cleavage, adpribose, estoppey, ivan, sadoul, jeanclaude, martinou, overexpression, proteases, family, access, author, permissions, research, essential, optional, media, personal, parties, policy, journals, journal, original, paper, january, cysteine, protease, staurosporinemediated,

Topics {✒️}

nature portfolio permissions reprints privacy policy nature advertising jean-claude martinou social media author correspondence staurosporine-mediated apoptosis staurosporine-induced apoptosis ice/ced-3 gene families ice/ced-3 gene family personal data data protection permissions cell death pathway enhancing cell death cell death differ polymerase u1-70k ribonucleoprotein bcl-2 prevents activation b-cell malignancies privacy cpp32 cysteine protease diverse cell types cpp32/yama/apopain bcl-2 protein family bcl-2 family proteins journals search log explore content similar content european economic area plan-les ouates article estoppey accepting optional cookies bcl-2 prevents cleavage bcl-2 controls pcd inhibit pcd mediated manage preferences protects hela cells u1-70 kd proteins content cpp32 activation article cite cell types https ice/ced-3 bcl-2 overexpression limited proteolysis gougeon rights sadoul

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis
         description:Members of the the Bcl-2 and ICE/ced-3 gene families have been implicated as essential components in the control of the cell death pathway. Bcl-2 overexpression can prevent programmed cell death (PCD) in different cell types. ICE/ced-3-like proteases are synthesized as pro-enzymes and are activated by limited proteolysis. When overexpressed in diverse cell types, they trigger PCD. Bcl-2 can inhibit PCD mediated by these proteases, although as yet it is not clear at what specific step in the cell death pathway the protein acts. Here, we demonstrate that CPP32/Yama/Apopain, a member of the ICE/Ced-3 gene family, is processed during staurosporine-induced apoptosis in HeLa cells and that concomitant with CPP32 activation, two other proteins, poly (ADP-ribose) polymerase (PARP) and the U1-70 K small ribonucleoprotein, also undergo proteolysis. Overexpression of Bcl-2 prevents cleavage of CPP32, PARP and U1-70 K and protects HeLa cells from PCD. These results demonstrate that Bcl-2 controls PCD, by acting upstream of CPP32/Yama/Apopain.
         datePublished:
         dateModified:
         pageStart:34
         pageEnd:38
         sameAs:https://doi.org/10.1038/sj.cdd.4400205
         keywords:
            apoptosis
            CPP32
            proteases
            Bcl-2
            staurosporine
            poly (ADP ribose) polymerase
            U1-70K ribonucleoprotein
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Stem Cells
            Apoptosis
            Cell Cycle Analysis
         image:
         isPartOf:
            name:Cell Death & Differentiation
            issn:
               1476-5403
               1350-9047
            volumeNumber:4
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sandrine Estoppey
               affiliation:
                     name:Glaxo Insititute for Molecular Biology
                     address:
                        name:Glaxo Insititute for Molecular Biology, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ivan Rodriguez
               affiliation:
                     name:Glaxo Insititute for Molecular Biology
                     address:
                        name:Glaxo Insititute for Molecular Biology, Switzerland
                        type:PostalAddress
                     type:Organization
                     name:Centre Médical Universitaire, Dept of Pathology
                     address:
                        name:Centre Médical Universitaire, Dept of Pathology, Geneva
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rémy Sadoul
               affiliation:
                     name:Glaxo Insititute for Molecular Biology
                     address:
                        name:Glaxo Insititute for Molecular Biology, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jean-Claude Martinou
               affiliation:
                     name:Glaxo Insititute for Molecular Biology
                     address:
                        name:Glaxo Insititute for Molecular Biology, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis
      description:Members of the the Bcl-2 and ICE/ced-3 gene families have been implicated as essential components in the control of the cell death pathway. Bcl-2 overexpression can prevent programmed cell death (PCD) in different cell types. ICE/ced-3-like proteases are synthesized as pro-enzymes and are activated by limited proteolysis. When overexpressed in diverse cell types, they trigger PCD. Bcl-2 can inhibit PCD mediated by these proteases, although as yet it is not clear at what specific step in the cell death pathway the protein acts. Here, we demonstrate that CPP32/Yama/Apopain, a member of the ICE/Ced-3 gene family, is processed during staurosporine-induced apoptosis in HeLa cells and that concomitant with CPP32 activation, two other proteins, poly (ADP-ribose) polymerase (PARP) and the U1-70 K small ribonucleoprotein, also undergo proteolysis. Overexpression of Bcl-2 prevents cleavage of CPP32, PARP and U1-70 K and protects HeLa cells from PCD. These results demonstrate that Bcl-2 controls PCD, by acting upstream of CPP32/Yama/Apopain.
      datePublished:
      dateModified:
      pageStart:34
      pageEnd:38
      sameAs:https://doi.org/10.1038/sj.cdd.4400205
      keywords:
         apoptosis
         CPP32
         proteases
         Bcl-2
         staurosporine
         poly (ADP ribose) polymerase
         U1-70K ribonucleoprotein
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Stem Cells
         Apoptosis
         Cell Cycle Analysis
      image:
      isPartOf:
         name:Cell Death & Differentiation
         issn:
            1476-5403
            1350-9047
         volumeNumber:4
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sandrine Estoppey
            affiliation:
                  name:Glaxo Insititute for Molecular Biology
                  address:
                     name:Glaxo Insititute for Molecular Biology, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ivan Rodriguez
            affiliation:
                  name:Glaxo Insititute for Molecular Biology
                  address:
                     name:Glaxo Insititute for Molecular Biology, Switzerland
                     type:PostalAddress
                  type:Organization
                  name:Centre Médical Universitaire, Dept of Pathology
                  address:
                     name:Centre Médical Universitaire, Dept of Pathology, Geneva
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rémy Sadoul
            affiliation:
                  name:Glaxo Insititute for Molecular Biology
                  address:
                     name:Glaxo Insititute for Molecular Biology, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jean-Claude Martinou
            affiliation:
                  name:Glaxo Insititute for Molecular Biology
                  address:
                     name:Glaxo Insititute for Molecular Biology, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Differentiation
      issn:
         1476-5403
         1350-9047
      volumeNumber:4
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Glaxo Insititute for Molecular Biology
      address:
         name:Glaxo Insititute for Molecular Biology, Switzerland
         type:PostalAddress
      name:Glaxo Insititute for Molecular Biology
      address:
         name:Glaxo Insititute for Molecular Biology, Switzerland
         type:PostalAddress
      name:Centre Médical Universitaire, Dept of Pathology
      address:
         name:Centre Médical Universitaire, Dept of Pathology, Geneva
         type:PostalAddress
      name:Glaxo Insititute for Molecular Biology
      address:
         name:Glaxo Insititute for Molecular Biology, Switzerland
         type:PostalAddress
      name:Glaxo Insititute for Molecular Biology
      address:
         name:Glaxo Insititute for Molecular Biology, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sandrine Estoppey
      affiliation:
            name:Glaxo Insititute for Molecular Biology
            address:
               name:Glaxo Insititute for Molecular Biology, Switzerland
               type:PostalAddress
            type:Organization
      name:Ivan Rodriguez
      affiliation:
            name:Glaxo Insititute for Molecular Biology
            address:
               name:Glaxo Insititute for Molecular Biology, Switzerland
               type:PostalAddress
            type:Organization
            name:Centre Médical Universitaire, Dept of Pathology
            address:
               name:Centre Médical Universitaire, Dept of Pathology, Geneva
               type:PostalAddress
            type:Organization
      name:Rémy Sadoul
      affiliation:
            name:Glaxo Insititute for Molecular Biology
            address:
               name:Glaxo Insititute for Molecular Biology, Switzerland
               type:PostalAddress
            type:Organization
      name:Jean-Claude Martinou
      affiliation:
            name:Glaxo Insititute for Molecular Biology
            address:
               name:Glaxo Insititute for Molecular Biology, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Glaxo Insititute for Molecular Biology, Switzerland
      name:Glaxo Insititute for Molecular Biology, Switzerland
      name:Centre Médical Universitaire, Dept of Pathology, Geneva
      name:Glaxo Insititute for Molecular Biology, Switzerland
      name:Glaxo Insititute for Molecular Biology, Switzerland

Social Networks {👍}(1)

External Links {🔗}(15)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

6.22s.